Recent News

• 12.12.2025 - 4 - Statement of changes in beneficial ownership of securities
• 12.12.2025 - 4 - Statement of changes in beneficial ownership of securities
• 12.12.2025 - 4 - Statement of changes in beneficial ownership of securities
• 12.12.2025 - 4 - Statement of changes in beneficial ownership of securities
• 12.12.2025 - 4 - Statement of changes in beneficial ownership of securities
• 12.05.2025 - 8-K - Current report
• 11.25.2025 - PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
• 11.18.2025 - 4 - Statement of changes in beneficial ownership of securities
• 11.18.2025 - SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership
• 11.18.2025 - 8-K/A - Current report

Recent Filings

• 12.05.2025 - 8-K Current report
• 11.18.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 11.18.2025 - 8-K/A Current report
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.31.2025 - 8-K Current report
• 10.06.2025 - DEF 14A Other definitive proxy statements